Chamni's Eye PCL (CEYE) fair value: what the stock is really worth
As of Sep 24, 2026: fair value of Chamni's Eye PCL THB 1.19, price THB 1.20, upside -0.8%, quality 48 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Watch Chamni's Eye PCL for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for freePro now: $1 first month
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 24, 2026.
How to read this chart
53‑month range 1.11 THB – 5.11 THB · fair‑value band 0.6200 THB – 1.19 THB · the 1.20 THB price screens above the 1.19 THB fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Sep 24, 2026.
Follow Chamni's Eye PCL in your weekly email
Every Wednesday you see whether Chamni's Eye PCL is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Chamni's Eye Public Company Limited, together with its subsidiaries, engages in the still image production and retouching for advertising media in Thailand. The company is involved in the moving image production and editing for advertising media; and studio rental services.
Show more
Chamni's Eye Public Company Limited, together with its subsidiaries, engages in the still image production and retouching for advertising media in Thailand. The company is involved in the moving image production and editing for advertising media; and studio rental services. It also offers end-to-end creative and production services, including brand strategy, creative development, advertising production, social media management, media planning and buying, and online publishing platform, as well as sound recording, editing film, and video services. The company was founded in 1991 and is based in Bangkok, Thailand.
Stock analysis
Chamni's Eye PCL (CEYE) currently trades at 1.20 THB, while our model-based Fair Value estimate is 1.19 THB, implying the stock looks roughly 0.8% fairly valued today.
Show more
Valuation
Bull case: the Asset-Based group reads highest at a median of 1.47 THB per share, and 12 of the 25 models we run sit above the 1.20 THB price.
Bear case: the Growth Earnings group reads lowest at 0.2900 THB, and 13 of the 25 models stay below the price. Evidence for this calculation is low.
Scenario range: 0.6200 THB (bear) to 1.19 THB (bull), the price of 1.20 THB sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 48/100 (below-average quality), in the Consumer Cyclical sector.
Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.
Chamni's Eye PCL reported revenue of 439M THB in FY2025 versus 266M THB in FY2021, a compound +13.3%/yr. Reported net income was 4.2M THB in FY2025, compounding −37.9%/yr from FY2021.
Key figures
Market cap 348M THB (≈ $10.4M) · P/S ratio 0.81 · Dividend yield 6.3% · Net margin 1.0% · Return on equity 0.1% · Return on assets (EBIT) 7.8% · Operating margin 9.1% · Revenue (TTM) 406M THB.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 42 out of 100 (low confidence).
What moves the price
The share trades about 31% below its 52-week high and 8% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Consumer Cyclical peers we cover trades at 38% fair-value upside, at −1%, CEYE screens richer than that median.
Fair Value models
Bear 0.6200 THBFair Value 1.19 THBBull 1.19 THB
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.85/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 1 year
+6.0%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+6.5%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+13.8%
Start year 2020 (pandemic)
Revenue growth 8 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+7.2%
’17
’18
’19
’20
’21
’22
’23
’24
’25
What shareholders gained per year (last 5 years), in THB ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Measured in THB: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
−26.5%
Earnings growth per share plus dividend.
Earnings per share, growth per year−32.7%
Dividend (yield on the price)6.3%
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.8% → 6%
Growth Forecast
Little optimism in the price
The price assumes less growth than the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
−4.9%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect
n/a
No analyst forecast available.
After inflation (Thailand: IMF forecast 1.2% a year to 2030, 1.1% from 2016 to 2025) that is about −6.1% a year for the price.
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Leisure · 189 stocks
Beats the industry median on 5/11 measures
A mixed picture versus its industry peers.
Valuation
Quality Score48 · Below median
Fair Value upside−4% · Below median
Profitability
Return on equity (TTM)0% · Below median
Return on assets2% · Below median
Net margin (TTM)0% · Below median
Operating margin (TTM)9% · Above median
Growth and dividend
Revenue growth−26% · Bottom 25%
Dividend yield (TTM)6.3% · Top 25%
Balance sheet
Debt / equity0.03× · Below median
Valuation Multiplesvs Leisure median · lower = cheaper
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Is Chamni's Eye PCL (CEYE) overvalued or undervalued?
As of Sep 24, 2026, our model estimates a fair value of 1.19 THB versus a price of 1.20 THB, about −1% upside (fairly valued).
What is the fair value of CEYE?
Our model-based fair value for Chamni's Eye PCL is 1.19 THB (as of Sep 24, 2026), built from audited fundamentals. The current price: 1.20 THB.
What is the quality score of CEYE?
Chamni's Eye PCL has a Quality Score of 48/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Chamni's Eye PCL (CEYE)?
Our model-based price target is the fair value of 1.19 THB (as of Sep 24, 2026) from 25 valuation models. Cautious scenario 0.6200 THB, optimistic scenario 1.19 THB. It is a calculation from audited fundamentals, not an analyst target.
What is the Chamni's Eye PCL stock forecast for 2026?
Our models put fair value at 1.19 THB, about −1% upside versus a price of 1.20 THB (fairly valued). Cautious scenario 0.6200 THB, optimistic scenario 1.19 THB. The calculation is refreshed regularly with new filings.
What is the revenue of Chamni's Eye PCL (CEYE)?
Chamni's Eye PCL reported trailing-twelve-month revenue of about 406M THB (latest available figure, as of Sep 24, 2026).
Does Chamni's Eye PCL pay a dividend?
Chamni's Eye PCL currently shows a dividend yield of about 6.25% relative to its recent price (as of Sep 24, 2026).
What growth is priced into Chamni's Eye PCL (CEYE)?
For today's price to be fair in a discounted-cash-flow model, Chamni's Eye PCL would have to grow free cash flow by -4.9 % per year for five years (discount rate 10.1 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +13.8 % per year. As of Sep 24, 2026.
What discount rate (WACC) does the fair value of CEYE use?
Our models discount Chamni's Eye PCL at 10.1 %: a base by market capitalisation (nano), damped by beta 0.09, country premium for Thailand. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Chamni's Eye PCL that is -4.9 % per year a year over ten years, using the same discount rate (10.1 %) and the same formula as our fair value.
How much growth has Chamni's Eye PCL (CEYE) delivered so far?
Over the past 5 years revenue at Chamni's Eye PCL grew +13.8 % a year. The price currently implies -4.9 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Chamni's Eye PCL (CEYE) growing?
The median revenue growth in the sector is +2.6 % a year. That is the yardstick for the growth priced into Chamni's Eye PCL (-4.9 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Chamni's Eye PCL (CEYE)?
The free-cash-flow yield on the price is 8.26 %: that much free cash flow Chamni's Eye PCL produces per unit of market value. When it exceeds the discount rate of our models (10.1 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Chamni's Eye PCL (CEYE)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Chamni's Eye PCL it is 1.19 THB per share (as of Sep 24, 2026), against a price of 1.20 THB. It is the blended result of 25 valuation models (cash flow, earnings, asset, dividend).
Is Chamni's Eye PCL stock overvalued or undervalued in 2026?
As of Sep 24, 2026, CEYE trades above its calculated fair value: price 1.20 THB, fair value 1.19 THB, a gap of about −1% (fairly valued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of CEYE?
No. The price is what the market pays today (1.20 THB); the fair value is what the company's own numbers justify (1.19 THB). For Chamni's Eye PCL the two are 0.0100 THB per share apart. That gap is exactly why we show both numbers side by side.
How much is Chamni's Eye PCL worth?
The market values Chamni's Eye PCL at about 348M THB (market capitalisation, as of Sep 24, 2026). Per share that is 1.20 THB; our models calculate a fair value of 1.19 THB per share.
What do the bullish and bearish scenarios say about CEYE?
Our models span a range for Chamni's Eye PCL: cautious scenario 0.6200 THB, base 1.19 THB, optimistic 1.19 THB per share (as of Sep 24, 2026, price 1.20 THB). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Chamni's Eye PCL (CEYE)?
Balance-sheet figures for Chamni's Eye PCL (as of Sep 24, 2026): return on equity 0.1%, debt of 0.03 per unit of equity. They feed the Quality Score of 48/100, which measures business quality independently of the share price.
How far is CEYE from its 52-week high?
Chamni's Eye PCL trades at 1.20 THB, about 31% below its 52-week high of 1.75 THB and 8% above the low of 1.11 THB (as of Sep 24, 2026). Distance from the high says nothing about value: that is what the fair value of 1.19 THB is for.
Which stocks are comparable to Chamni's Eye PCL?
From the same area (Consumer Cyclical) we also value ANTA Sports Products Limited, Pop Mart International Group, Amer Sports, Inc, Hasbro, Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Chamni's Eye PCL stock attractive at the current price?
The data as of Sep 24, 2026: price 1.20 THB, calculated fair value 1.19 THB (−1%), Quality Score 48/100, from 25 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of CEYE calculated?
We run Chamni's Eye PCL through 25 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of 1.19 THB, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.2 % above its aggregate fair value. Chamni's Eye PCL itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Chamni's Eye PCL (CEYE)?
The closing price on Sep 24, 2026 was 1.20 THB. Our model-based fair value is 1.19 THB, about −1% upside (fairly valued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Chamni's Eye PCL right now?
The price sits close to our fair value, market and models broadly agree here, little valuation tension. A fairly wide model range (0.6200 THB to 1.19 THB) leaves room in how you read the outcome. Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual.
Key figures of Chamni's Eye PCL
How large is the market capitalisation of Chamni's Eye PCL (CEYE)?
The market capitalisation of Chamni's Eye PCL is 348M THB (≈ $10.4M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Chamni's Eye PCL (CEYE)?
The price-to-sales ratio of Chamni's Eye PCL is 0.81 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What is the dividend yield of Chamni's Eye PCL (CEYE)?
The dividend yield of Chamni's Eye PCL is 6.3%. Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Chamni's Eye PCL (CEYE)?
The net margin of Chamni's Eye PCL is 1.0% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Chamni's Eye PCL (CEYE)?
The return on equity (ROE) of Chamni's Eye PCL is 0.1% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Chamni's Eye PCL (CEYE)?
On an EBIT basis the return on assets of Chamni's Eye PCL is 7.8% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Chamni's Eye PCL (CEYE)?
The operating margin of Chamni's Eye PCL is 9.1% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Chamni's Eye PCL (CEYE)?
Revenue at Chamni's Eye PCL is growing −25.9% versus a year earlier (3y avg +6.5%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Chamni's Eye PCL (CEYE)?
Earnings per share at Chamni's Eye PCL are growing −38.4% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net debt does Chamni's Eye PCL (CEYE) carry?
The net debt of Chamni's Eye PCL is 7.0M THB (fiscal year 2025, ≈ 0.2 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch Chamni's Eye PCL in the live analysis
One click puts Chamni's Eye PCL on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
